Skip to main content

ADVERTISEMENT

Acurate

Original Contribution
10/20/2022
Few data exist on immediate outcomes of the next-generation Acurate neo2 prosthesis (Boston Scientific), which is distinguished by an active sealing mechanism. We sought to determine procedural outcomes of transfemoral transcatheter aortic...
Few data exist on immediate outcomes of the next-generation Acurate neo2 prosthesis (Boston Scientific), which is distinguished by an active sealing mechanism. We sought to determine procedural outcomes of transfemoral transcatheter aortic...
Few data exist on immediate...
10/20/2022
Journal of Invasive Cardiology
Original Research
05/19/2022
Data are lacking regarding the outcomes of balloon postdilation (BPD) for the Acurate neo and neo2 devices. The aim of this study was to assess the impact of BPD in a large, single-center cohort of patients treated with the Acurate platform.
Data are lacking regarding the outcomes of balloon postdilation (BPD) for the Acurate neo and neo2 devices. The aim of this study was to assess the impact of BPD in a large, single-center cohort of patients treated with the Acurate platform.
Data are lacking regarding the...
05/19/2022
Journal of Invasive Cardiology
Case Report
02/08/2018
Severe iliofemoral arteriopathies precludes transfemoral access in approximately one-third of patients, but subclavian access represents an alternative option for these patients.
Severe iliofemoral arteriopathies precludes transfemoral access in approximately one-third of patients, but subclavian access represents an alternative option for these patients.
Severe iliofemoral...
02/08/2018
Vascular Disease Management